94500 Champigny sur Marne – France
Contact : firstname.lastname@example.org
Radhia M’kacher : Présidente directrice générale
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.Discover >
Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.Discover >
Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.
Our academic research developed over 20 years reliable, sensitive and automated methods to detect DNA damage. Cell Environment was created to transfer these techniques into the clinics.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
Cell Environment developed a high throughput genomic cytogenetic approach based on a very small amount of samples. This process associates telomere quantification to the analysis of chromosomal aberrations and the detection of chromosomal instability.
This approach is a break with the existent techniques. In order to transfer this approach in the clinics, we developed the kits of telomere and centromere staining as well as the software for automated analysis.
ACCOMPLISHMENTS / COLLABORATIONS / HIGHLIGHTS
The first flagship products resulting from this innovation are
A validation of the approach was performed against clinical cytogenetics. A patent has been filed. The company has been approved as an R&D provider since 2017.
Cell Environment has started the industrialization and commercialization phase and we are looking for partners for the distribution of kits and funds to make our solution more relevant.
In same field
IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.Discover
Bioinformatics service provider (gene expression, splicing, SNP, CNV, epigenetics, data integration).Discover
Design, development and commercialization of medical devices and services for the diagnosis of endometriosis.Discover
Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.Discover
AgenT is developing an unprecedented blood test to identify patients with Alzheimer's disease much earlier in disease course than current detection methods are able to do. The company also does drug repositioning research to identify compounds potentially active in the silent phase of Alzheimer's disease.Discover